Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001437749-25-012375
Filing Date
2025-04-18
Accepted
2025-04-18 16:31:08
Documents
16
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A mbrx20241231_10ka.htm   iXBRL 10-K/A 342940
2 EXHIBIT 31.3 ex_795966.htm EX-31.3 4785
3 EXHIBIT 31.4 ex_795967.htm EX-31.4 5056
  Complete submission text file 0001437749-25-012375.txt   605069

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA mbrx-20241231.xsd EX-101.SCH 3580
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mbrx-20241231_def.xml EX-101.DEF 17406
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE mbrx-20241231_lab.xml EX-101.LAB 23726
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mbrx-20241231_pre.xml EX-101.PRE 18446
18 EXTRACTED XBRL INSTANCE DOCUMENT mbrx20241231_10ka_htm.xml XML 6428
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

EIN.: 474671997 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-37758 | Film No.: 25850681
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)